论文部分内容阅读
杰隆集团成立至今,一直关注生物资源的现实价值和潜在价值,持久和可持续地实现生物资源价值最大化,已经成长为以生物产业为核心的高科技集团企业。杰隆企业集团有限公司(以下简称“杰隆集团”)利用转基因、体细胞打靶、体细胞克隆、酶工程等现代生物技术,致力于自主知识产权成果的产业化,逐步形成了以生物产业为核心的高科技产业集团。经过16年的自主知识产权成果产业化发展,杰隆集团在生物农业、生物医药、生物环保领域取得了一
Since its establishment, Geelong Group has always been concerned about the real value and potential value of biological resources. It has been able to maximize the value of biological resources in a sustained and sustainable manner and has grown into a high-tech group company with a focus on the biotechnology industry. Jelong Enterprise Group Co., Ltd. (hereinafter referred to as “Jelong Group”) is committed to the industrialization of its own intellectual property rights using modern biotechnology such as genetically modified, somatic cell targeting, somatic cell cloning and enzyme engineering, Industry as the core of the high-tech industry groups. After 16 years of industrialized development of independent intellectual property achievements, Jelong Group has won the first prize in the field of biological agriculture, biomedicine and bio-environmental protection